Vascular Endothelial Growth Factor-B Blockade with CSL346 in Diabetic Kidney Disease: A Phase 2A Randomized
Melisa Cooper1, David Z I Cherney2, Tom H Greene3
1CSL Behring LLC, King of Prussia, Pennsylvania.
Journal of the American Society of Nephrology : JASN
|August 16, 2024
Abstract
No abstract available in PubMed .


